{"DataElement":{"publicId":"7382377","version":"1","preferredName":"Kaposi Sarcoma Lesion Last Patient Visit Change Count","preferredDefinition":"Number of new Kaposi sarcoma lesions since the last study visit.","longName":"TOTLNSLV","context":"AMC","contextVersion":"1","DataElementConcept":{"publicId":"7372491","version":"1","preferredName":"Kaposi Sarcoma Lesion Last Patient Visit Change","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS)._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Coming after all others in time or space or degree or being the only one remaining._A visit by a patient or study participant to a medical professional._The act of alteration or modification; changed or altered in form or character.","longName":"7372488v1.0:7372489v1.0","context":"AMC","contextVersion":"1","ObjectClass":{"publicId":"7372488","version":"1","preferredName":"Kaposi Sarcoma Lesion","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).:A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","longName":"C9087:C3824","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB86C29E-8915-286B-E053-4EBD850A1C5A","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7372489","version":"1","preferredName":"Last Patient Visit Change","preferredDefinition":"Coming after all others in time or space or degree or being the only one remaining.:A visit by a patient or study participant to a medical professional.:The act of alteration or modification; changed or altered in form or character.","longName":"C25551:C39564:C25446","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Last","conceptCode":"C25551","definition":"Coming after all others in time or space or degree or being the only one remaining.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Patient Visit","conceptCode":"C39564","definition":"A visit by a patient or study participant to a medical professional.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB86C29E-8927-286B-E053-4EBD850A1C5A","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB86C29E-8938-286B-E053-4EBD850A1C5A","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-28","modifiedBy":"COLLIED","dateModified":"2020-08-26","changeDescription":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7382375","version":"1","preferredName":"Lesion Count","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Determining the number or amount of something.","longName":"7382375v1.0","context":"AMC","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3755216","version":"1","preferredName":"Lesion Count","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.:To determine the number or amount of something; the result of this activity.","longName":"C3824:C25463","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Count","conceptCode":"C25463","definition":"Determining the number or amount of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DC38EECE-7BC8-E7DD-E040-BB89AD4307AF","latestVersionIndicator":"Yes","beginDate":"2013-05-08","endDate":null,"createdBy":"GRANTD","dateCreated":"2013-05-08","modifiedBy":"ONEDATA","dateModified":"2013-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC49E364-06C6-0711-E053-4EBD850A5CEF","latestVersionIndicator":"Yes","beginDate":"2020-08-07","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-08-07","modifiedBy":"COLLIED","dateModified":"2020-08-25","changeDescription":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7283431","version":"1","longName":"CRF CDEs","context":"AMC","ClassificationSchemeItems":[{"publicId":"7312662","version":"1","longName":"KS","context":"AMC"}]}],"AlternateNames":[{"name":"TRORRES_NUMNEW3","type":"OID, AMC","context":"AMC"},{"name":"TRORRES_NUMNEW2","type":"OID, AMC","context":"AMC"},{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"TRORRES_NUMNEW1","type":"OID, AMC","context":"AMC"},{"name":"KAP_LSN_CHNGE_CT","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"AMC Question Text 2","type":"Alternate Question Text","description":"Number of NEW Lesions Compared to Last Visit","url":null,"context":"AMC"},{"name":"Total number of new lesions s","type":"Preferred Question Text","description":"Total number of new lesions since last visit","url":null,"context":"AMC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC49FFC6-8817-0713-E053-4EBD850A06C5","latestVersionIndicator":"Yes","beginDate":"2020-08-07","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-08-07","modifiedBy":"TSESU","dateModified":"2023-08-09","changeDescription":"Curated for AMC 107 protocol DC","administrativeNotes":"8/9/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"}}